Latest news
Sugar substitutes were sold as metabolic shortcuts. The evidence is getting harder to ignore
A new review and meta-analysis in Current Atherosclerosis Reports found that non-nutritive sweeteners may not be metabolically inert. Across randomised trials and observational evidence, artificial and low-calorie sweeteners were linked to signals of disrupted glucose-insulin regulation, microbiome changes and higher cardiometabolic risk. The policy problem is not whether sugar is healthy. It is whether “sugar-free”…
Sanofi’s Tzield moves type 1 diabetes into disease modification, but access may decide who benefits
WHO is preparing to ration the obesity drug revolution before it becomes another access disaster
CAR-T Starts Moving From Factory Medicine to In-Patient Engineering
AML’s Frontline Future Starts With Finding the Mutation Fast
FSHD Gets a Stronger Biological Signal
ALS Immunotherapy Moves Into the Extension Phase
Measles Deaths in England Expose the Cost of Missed Protection
Europe’s AMR Strategy Depends on the Lab Result Being Right
Heatwaves are emerging as a cardiovascular risk factor, prompting calls for stronger climate adaptation and public health policies
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.